Member Info for Hartlebury

so yes, a long wait for under 50's to get vaccinated but not testing not them sounds misreported/misunderstood

I hadn't heard that, Pfizer's they said they don't know response in older people and it wasn't tested for children. Under 50's who are not CV would be down on the priority list when roll out does happen but I'm pretty sure testing is being done on all adult ages.

It isn't new news though is it? Didn't Prof Jo Martin tweet back in October that Samba and PrimerDesign machines were being installed across the NHS? I'm sure the demand is so high that they need more than one supplier. Also, £2.3m was donated to Addenbrookes to buy Samba machines ..https://www.cam.ac.uk/research/news/rapid-covid-19-diagnostic-test-developed-by-cambridge-team-to-be-deployed-in-hospitals

The Samba looks great, but simply won't be as appealing to UK Government because of a)much higher cost and b) US product rather than UK supplier. That's not to say they won't get bought, I just don't believe they would be the preferred supplier.

You do understand the difference between a vaccine and a medicine right?

‘Many experts have called for between 4 million and 15 million tests a day to suppress the virus’ https://www.google.co.uk/amp/s/www.nbcnews.com/news/amp/ncna1248243

I like to think the directors dealings and the PD tweets are GM’s way of metaphorically stroking our hair - ‘don’t worry, it’ll all be fine’ ...!

Kaeren, Troublesome...we were speculating the other day about what Versalab might be and I have a new theory...do you think it could it be the LAMP testing? The R&D update refers to a LAMP product being launched in Jan 2021, which is why they wouldn't be naming it now, gives results in 20 minutes or less and more cost effective and they are seeking manufacturing partners...could they be testing this in care homes now? This occurred to me as I was pondering the expense of pcr for care homes earlier.

Novacyt Insider mentioned that German multiplex kit in article on multiplex tests 29 October. - thought to be the first of its kind.

They have a multiplex kit for covid/flu too (HCP use only)

BA testing company is SourceBio via Nomad travel

bah - opposite!

Interesting that they say sensitivity >99% but no mention of specificity!

Hope you are right Porky!

Spedders I agree, it may eventually be the case that covid and its vaccines do become like the flu, but only once herd immunity is reached (70% of population successfully vaccinated?) and there is good data about how long that immunity lasts and what effect mutations have. That is going to take a very long time - I would guess easily more than a year - and a lot of testing. Even at that point, testing will still be crucial in certain situations, such as hospitals and care homes. The big difference between flu and covid is the high level of asymptomatic occurrences, so regular testing of HCP's would seem important, also I would see it like MRSA in hospitals where great care would need to be taken prior to surgery etc. Following on from this pandemic, as Morningsun said, we need to be well prepared for the next and that means being able to mobilise mass testing at short notice.

Further into the future, did you hear Matt Han**** on Monday when he spoke about the investment in diagnostics in the NHS? He described the mega labs as "a permanent part of the UK's new diagnostics industry'...not just for this pandemic but longing to the future'. This is a massive investment in the NHS and a step change in its strategy and I believe Novacyt is at the heart of it. Its NPT machines, such as PCR, can test for a whole list of conditions, including cancer. Once embedded in the NHS this diagnostic capability will be key and Nova will be hugely cash rich very soon, making it able to diversify into other areas in the medium term.

Sorry Wilson (and Porky), I meant your concerns about LFT’s in care homes.

I share Porky’s concerns about the use of LFT’s in car homes, can’t believe they could be relied upon when the risk is so high. One thing I am curious about and I don’t know if maybe Shaun knows the answer, how cost effective is the Q16, insofar as its great if you need multiple tests done at the same time, but there are some small care homes out there, I’d be surprised if there weren’t some days when my dad’s home gets less than 10 visitors. Would it make testing them using a q16/32 disproportionately expensive and if so is there an alternative that might be better?

What do you mean how do I explain it? Apparently the arrangement was made to sell the shares then back in May but once all information is in the market they are allowed to sell...

It is a seemingly inconsequential amount Nordell, but £ is all relative to the person investing it, we don’t know their financial circumstances. Also it’s by someone with a connection to senior management, not a director with a possible incentive to try to help support the share price (which of course does sometimes happen). The fact that the disclosure is slightly late suggests to me that maybe she didn’t even realise it had to be disclosed.

Need announcing not news announcing. Why do I have such a problem with autocorrect on this site?

Har it isn’t a legal financial threshold but if a contract was won (or lost) that was so large as to push the performance outside the reasonable expectations based on past performance or forecasts that are in the public domain then that would qualify as price sensitive and news announcing. As the range in the forecasts used by Numis/SP is pretty large then that leaves some scope!